For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Complete Invesco Nasdaq Free Cash Flow Achievers ETF funds overview by Barron's. View the QOWZ funds market news ...

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2022. Fourth Quarter 2022 Financial Highlights: Revenue ...

DXCM's expanding CGM reach, G7 15 Day rollout and international momentum support growth, but can reimbursement and cost risks ...

Shares of DexCom Inc. DXCM advanced 3.47% to $71.25 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX remaining mostly unchanged at 7, ...

BlackRock's Mid-Cap Growth Equity Fund reported a -4.57% return in Q1 2026, outperforming its Russell Midcap benchmark. Read ...

If you are wondering whether DexCom stock still offers value after a choppy few years, this article walks through what the ...

US stock market closed mixed as the S&P 500 and Nasdaq slipped on AI and chip stock weakness, while healthcare stocks gained and the Dow ended the week higher.

Natera delivers robust revenue growth, raising 2026 guidance to $2.74–$2.82 billion, but remains unprofitable. Read more on ...

The Nasdaq Composite posted its fifth consecutive losing session Friday as investors rotated out of key technology stocks and ...

Teleflex reported 2025 compensation for top executives, including two who left after the medtech CDMO sold off some big ...

Abbott Laboratories (NYSE:ABT | ABT Price Prediction) at $90.53 is a Buy. The healthcare giant has been swept up in a ...